Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce

JAMA
June 22/29, 2021, Vol 325, No. 24, Pages 2419-2512
https://jamanetwork.com/journals/jama/currentissue

 

Research Letter
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce
Li Tang, PhD; Diego R. Hijano, MD, MSc; Aditya H. Gaur, MD, MBBS; et al.
free access has active quiz
JAMA. 2021;325(24):2500-2502. doi:10.1001/jama.2021.6564
This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.